{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T19:25:17Z","timestamp":1769109917329,"version":"3.49.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cardiovascular Medicine"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.tcm.2019.07.002","type":"journal-article","created":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T19:13:02Z","timestamp":1562613182000},"page":"257-262","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Use of statins in patients with peripheral artery disease"],"prefix":"10.1016","volume":"30","author":[{"given":"Egle","family":"Corrado","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3203-1592","authenticated-orcid":false,"given":"Antonino","family":"Mignano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Coppola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tcm.2019.07.002_bib0001","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(13)61249-0","article-title":"Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis","volume":"382","author":"Fowkes","year":"2013","journal-title":"Lancet"},{"issue":"18","key":"10.1016\/j.tcm.2019.07.002_bib0002","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2017.02.064","article-title":"Underuse of prevention and lifestyle counseling in patients with peripheral artery disease","volume":"69","author":"Berger","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2019.07.002_bib0003","first-page":"e726","article-title":"2016 AHA\/ ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the american college of cardiology\/ American heart association task force on clinical practice guidelines","volume":"135","author":"Gerhard-Herman","year":"2017","journal-title":"Circulation."},{"key":"10.1016\/j.tcm.2019.07.002_bib0004","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","volume":"39","author":"Aboyans","year":"2018","journal-title":"Eur Heart J."},{"issue":"5","key":"10.1016\/j.tcm.2019.07.002_bib0005","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.arcmed.2006.12.012","article-title":"Statins and peripheral arterial disease: effects on claudication, disease progression, and prevention of cardiovascular events","volume":"38","author":"Coppola","year":"2007","journal-title":"Arch Med Res"},{"key":"10.1016\/j.tcm.2019.07.002_bib0006","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1146\/annurev.pharmtox.45.120403.095748","article-title":"Pleiotropic effects of statins","volume":"45","author":"Liao","year":"2005","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.tcm.2019.07.002_bib0007","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0021-9150(03)00100-X","article-title":"Influence of 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase inhibitors on endothelial nitric oxide synthase and the formation of oxidants in the vasculature","volume":"169","author":"Parker","year":"2003","journal-title":"Atherosclerosis"},{"issue":"7","key":"10.1016\/j.tcm.2019.07.002_bib0008","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1210\/jc.2016-3717","article-title":"Statin therapy reduces future risk of lower-limb amputation in patients with diabetes and peripheral artery disease","volume":"102","author":"Hsu","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.tcm.2019.07.002_bib0009","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1161\/CIRCRESAHA.114.303505","article-title":"Pharmacological treatment and current management of peripheral artery disease","volume":"116","author":"Bonaca","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.tcm.2019.07.002_bib0010","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.jvs.2007.01.024","article-title":"The effect of intensified lipid-lowering therapy on long-term prognosis in patients with peripheral arterial disease","volume":"45","author":"Feringa","year":"2007","journal-title":"J Vasc Surg"},{"issue":"7","key":"10.1016\/j.tcm.2019.07.002_bib0011","article-title":"High-Intensity statin therapy is associated with improved survival in patients with peripheral artery disease","volume":"6","author":"Foley","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.tcm.2019.07.002_bib0012","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1161\/CIRCULATIONAHA.117.032361","article-title":"Association of statin dose with amputation and survival in patients with peripheral artery disease","volume":"137","author":"Arya","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2019.07.002_bib0013","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1056\/NEJM199202063260605","article-title":"Mortality over a period of 10 years in patients with peripheral arterial disease","volume":"326","author":"Criqui","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2019.07.002_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/S0002-9149(97)00904-1","article-title":"Effect of simvastatin on ischemic signs and symptoms in the Scandinavian Simvastatin Survival Study (4S)","volume":"81","author":"Pedersen","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.tcm.2019.07.002_bib0015","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1093\/eurheartj\/ehu080","article-title":"Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry","volume":"35","author":"Kumbhani","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.tcm.2019.07.002_bib0016","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jvs.2006.12.054","article-title":"Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions","volume":"45","year":"2007","journal-title":"J Vasc Surg"},{"issue":"6","key":"10.1016\/j.tcm.2019.07.002_bib0017","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.jvs.2013.06.069","article-title":"Statin use and lower extremity amputation risk in nonelderly diabetic patients","volume":"58","author":"Sohn","year":"2013","journal-title":"J Vasc Surg"},{"issue":"2","key":"10.1016\/j.tcm.2019.07.002_bib0018","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.vph.2014.09.001","article-title":"Statin therapy in lower limb peripheral arterial disease: systematic review and meta-analysis","volume":"63","author":"Antoniou","year":"2014","journal-title":"Vascul Pharmacol"},{"issue":"5","key":"10.1016\/j.tcm.2019.07.002_bib0019","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.jvs.2006.07.015","article-title":"Prospective multicenter study of quality of life before and after lower extremity vein bypass in 1404 patients with critical limb ischemia","volume":"44","author":"Nguyen","year":"2006","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.tcm.2019.07.002_bib0020","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.jacc.2013.09.073","article-title":"Association between statin medications and mortality, major adverse cardiovascular event, and amputation-free survival in patients with critical limb ischemia","volume":"63","author":"Westin","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"Oct (10)","key":"10.1016\/j.tcm.2019.07.002_bib0021","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/j.jvir.2016.05.037","article-title":"The influence of statin therapy on restenosis in patients who underwent nitinol stent implantation for de novo femoropopliteal artery Disease: two-year follow-up at a single center","volume":"27","author":"Kim","year":"2016","journal-title":"J Vasc Interv Radiol"},{"issue":"Oct (4)","key":"10.1016\/j.tcm.2019.07.002_bib0022","article-title":"Lipid-lowering for peripheral arterial disease of the lower limb","author":"Aung","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"Jan (4)","key":"10.1016\/j.tcm.2019.07.002_bib0023","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1161\/CIRCULATIONAHA.117.032235","article-title":"Low-density lipoprotein cholesterol lowering with evolocumab and outcomes in patients with peripheral artery disease: insights from the Fourier trial (Further cardiovascular outcomes research with PCSK9 inhibition in subjects with elevated risk)","volume":"137","author":"Bonaca","year":"2018","journal-title":"Circulation"},{"issue":"Dec (6)","key":"10.1016\/j.tcm.2019.07.002_bib0024","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.jvs.2016.08.094","article-title":"Statin use in patients with peripheral arterial disease","volume":"64","author":"Harris","year":"2016","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.tcm.2019.07.002_bib0025","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jvs.2015.08.058","article-title":"Preoperative antiplatelet and statin treatment was not associated with reduced myocardial infarction after high-risk vascular operations in the vascular quality initiative","volume":"63","author":"De Martino","year":"2016","journal-title":"J Vasc Surg"},{"issue":"Nov","key":"10.1016\/j.tcm.2019.07.002_bib0026","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol","author":"Grundy","year":"2018","journal-title":"Circulation."},{"issue":"Feb (1)","key":"10.1016\/j.tcm.2019.07.002_bib0027","first-page":"75","article-title":"Medical management of patients with peripheral arterial disease","volume":"34","author":"Poredo\u0161","year":"2015","journal-title":"Int Angiol"},{"key":"10.1016\/j.tcm.2019.07.002_bib0028","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3233\/CH-2011-1386","article-title":"High-dose atorvastatin treatment in patients with peripheral arterial disease: effects on platelet aggregation, blood rheology and plasma homocysteine","volume":"47","author":"Van der Loo","year":"2011","journal-title":"Clin Hemorheol Microcirc"},{"key":"10.1016\/j.tcm.2019.07.002_bib0029","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.clinthera.2007.02.008","article-title":"Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy","volume":"29","author":"Silva","year":"2007","journal-title":"Clin Ther"},{"key":"10.1016\/j.tcm.2019.07.002_bib0030","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.amjcard.2010.03.033","article-title":"Comparison of atorvastatin 80mg\/day versus simvastatin 20 to 40mg\/day on frequency of cardiovascular events late (five years) after acute myocar- dial infarction (from the incremental decrease in end points through aggressive lipid lowering [IDEAL] trial)","volume":"106","author":"Pedersen","year":"2010","journal-title":"Am J Cardiol"},{"issue":"Jul","key":"10.1016\/j.tcm.2019.07.002_bib0031","article-title":"Utilization of vasculoprotective therapy for peripheral artery Disease: a systematic review and Meta-analysis","author":"Hackam","year":"2018","journal-title":"Am J Med"},{"issue":"Apr (14)","key":"10.1016\/j.tcm.2019.07.002_bib0032","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1161\/CIRCULATIONAHA.117.033092","article-title":"Statins in peripheral artery Disease: what are we waiting For?","volume":"137","author":"Aday","year":"2018","journal-title":"Circulation"},{"issue":"Jun (3)","key":"10.1016\/j.tcm.2019.07.002_bib0033","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/1358863X18758915","article-title":"Under-utilization of statin medications in patients with peripheral artery disease or cerebrovascular disease","volume":"23","author":"Armstrong","year":"2018","journal-title":"Vasc Meditor"},{"issue":"Jun (3)","key":"10.1016\/j.tcm.2019.07.002_bib0034","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1177\/1358863X18758914","article-title":"Statin prescription rates and their facility-level variation in patients with peripheral artery disease and ischemic cerebrovascular disease: insights from the department of veterans affairs","volume":"23","author":"McBride","year":"2018","journal-title":"Vasc Med"},{"issue":"Feb (1)","key":"10.1016\/j.tcm.2019.07.002_bib0035","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/1358863X07084911","article-title":"The impact of peripheral arterial disease on health-related quality of life in the peripheral arterial disease Awareness, Risk, and Treatment: new resources for survival (PARTNERS) program","volume":"13","author":"Regensteiner","year":"2008","journal-title":"Vasc Med"},{"key":"10.1016\/j.tcm.2019.07.002_bib0036","doi-asserted-by":"crossref","first-page":"371","DOI":"10.4103\/0256-4947.83219","article-title":"Suboptimal use of risk reduction therapy in peripheral arterial disease pa- tients at a major teaching hospital","volume":"31","author":"Al-Omran","year":"2011","journal-title":"Ann Saudi Med"},{"issue":"8","key":"10.1016\/j.tcm.2019.07.002_bib0037","doi-asserted-by":"crossref","first-page":"7961","DOI":"10.3390\/ijerph110807961","article-title":"Effective- ness of a new exercise program after lower limb arterial blood flow surgery in patients with peripheral arterial dis-ease: a randomized clinical trial","volume":"11","author":"Jakubseviciene","year":"2014","journal-title":"Int J Environ Res PublicHealth"},{"key":"10.1016\/j.tcm.2019.07.002_bib0038","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ejvs.2009.06.002","article-title":"Drug therapy for improving walking distance in intermittent claudication: a systematic review and meta-analysis of robust randomized controlled studies","volume":"38","author":"Momsen","year":"2009","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"Dec (21)","key":"10.1016\/j.tcm.2019.07.002_bib0039","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1016\/j.jacc.2014.08.041","article-title":"Implications of the 2013 ACC\/AHA cholesterol guidelines for adults in contemporary cardiovascular practice: insights from the NCDR PINNACLE registry","volume":"64","author":"Maddox","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"Jul\u2013Aug (4)","key":"10.1016\/j.tcm.2019.07.002_bib0040","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ihj.2017.05.016","article-title":"Implications of the 2013 ACC\/AHA cholesterol guidelines on contemporary clinical practice for patients with atherosclerotic coronary and peripheral arterial disease","volume":"69","author":"Gunasekaran","year":"2017","journal-title":"Indian Heart J"}],"container-title":["Trends in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173819300945?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173819300945?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T04:59:18Z","timestamp":1760936358000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1050173819300945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S1050173819300945"],"URL":"https:\/\/doi.org\/10.1016\/j.tcm.2019.07.002","relation":{},"ISSN":["1050-1738"],"issn-type":[{"value":"1050-1738","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of statins in patients with peripheral artery disease","name":"articletitle","label":"Article Title"},{"value":"Trends in Cardiovascular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tcm.2019.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}